rs12357206

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.*20-799C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.357 in 152,016 control chromosomes in the GnomAD database, including 12,238 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 12238 hom., cov: 32)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.516

Publications

5 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.507 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020987.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_020987.5
MANE Select
c.*20-799C>T
intron
N/ANP_066267.2
ANK3
NM_001204404.2
c.*20-799C>T
intron
N/ANP_001191333.1Q12955-4
ANK3
NM_001320874.2
c.*20-799C>T
intron
N/ANP_001307803.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000280772.7
TSL:1 MANE Select
c.*20-799C>T
intron
N/AENSP00000280772.1Q12955-3
ANK3
ENST00000373827.6
TSL:1
c.*20-799C>T
intron
N/AENSP00000362933.2Q12955-5
ANK3
ENST00000355288.6
TSL:1
c.*20-799C>T
intron
N/AENSP00000347436.2Q12955-6

Frequencies

GnomAD3 genomes
AF:
0.357
AC:
54257
AN:
151896
Hom.:
12234
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0989
Gnomad AMI
AF:
0.639
Gnomad AMR
AF:
0.339
Gnomad ASJ
AF:
0.540
Gnomad EAS
AF:
0.185
Gnomad SAS
AF:
0.414
Gnomad FIN
AF:
0.366
Gnomad MID
AF:
0.399
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.411
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.357
AC:
54264
AN:
152016
Hom.:
12238
Cov.:
32
AF XY:
0.352
AC XY:
26160
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.0986
AC:
4093
AN:
41504
American (AMR)
AF:
0.338
AC:
5167
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.540
AC:
1874
AN:
3470
East Asian (EAS)
AF:
0.184
AC:
953
AN:
5170
South Asian (SAS)
AF:
0.417
AC:
1990
AN:
4776
European-Finnish (FIN)
AF:
0.366
AC:
3863
AN:
10568
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.512
AC:
34748
AN:
67926
Other (OTH)
AF:
0.415
AC:
877
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1578
3157
4735
6314
7892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.456
Hom.:
48803
Bravo
AF:
0.342

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.7
DANN
Benign
0.78
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12357206; hg19: chr10-61790383; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.